OUR PRODUCTS

MOBILE APPS

GENERAL INFO

UTHR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

United Therapeutics (UTHR) Earnings Date & Reports

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

UTHR is expected to report earnings to rise 15.29% to $7.39 per share on October 29

United Therapeutics UTHR Stock Earnings Reports

Q3'25

Est.

$7.39

Q2'25

Missed

by $0.94

Q1'25

Beat

by $0.10

Q4'24

Missed

by $0.49

Q3'24

Missed

by $0.14

The last earnings report on July 30 showed earnings per share of $6.41, missing the estimate of $7.35. With 144.55K shares outstanding, the current market capitalization sits at 13.64B.

View a ticker or compare two or three

Compare

UTHR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For UTHR
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. UTHR showed earnings on July 30, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

1000 Spring Street

Phone

+1 301 608-9292

Employees

1168

Web

https://www.unither.com